Ticker · CUSIP 36269B105

GANX

GAIN THERAPEUTICS INC
···Share
Holders (tracked)
5
Combined shares
141,382
Combined value
$455.3K
Last close
Quarter
2025Q4
Tracked holders · last 8 quarters
+2 vs previous quarter over the last 8.
562024Q12025Q4

SEC event timeline

5 events
  1. −373,558 shares · 2025Q4
    Position
  2. +14,002 shares · 2025Q4
    Position
  3. +32,480 shares · 2025Q4
    Position
  4. −108,700 shares · 2025Q4
    Position
  5. +32,100 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions2
Added to0
Trimmed1
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
3
$2.3M
2022Q2
3
$2.2M
2022Q3
3
$2K
2022Q4
3
$1.8M
2023Q1
6
$2.9M
2023Q2
6
$2.9M
2023Q3
6
$2.2M
2023Q4
7
$2.3M
2024Q1
6
$498K
2024Q2
3
$290K
2024Q3
1
$95K
2024Q4
3
$60K
2025Q1
3
$69K
2025Q2
2
$460K
2025Q3
3
$903K
2025Q4
5
$455K

Who owns GANX

5 super-investors · 2025Q4
Tracked stake
141.4K
shares
Combined value
$455K
% of shares outstanding
shares-out unknown
Quarter action mix
New2Trim1Sold2
#ManagerSharesValue
1Ken Griffin
Citadel Advisors
51.4K$166K
2Steve Cohen
Point72
32.5K$105K
3Ken Griffin
Citadel Advisors
26.1K$84K
4Renaissance Technologies17.4K$56K
5Izzy Englander
Millennium Mgmt
14.0K$45K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live GANX chart.
<iframe src="https://openstocks.me/embed/stock/GANX" width="100%" height="480" frameborder="0" loading="lazy" title="GANX chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>